Prediction of Pulmonary Fibrosis and the Development of Chronic Pulmonary Insufficiency in Patients Who Have Undergone Covid-19

After recovering from COVID-19, many patients complain about their health. Transferring Covid-19 does not mean that you can now forget about hospitals. Most people just remember about them. Complications after the virus are no less dangerous than the disease itself. Therefore, patients who have undergone coronavirus undergo in-depth medical examination. While we are feverishly developing an effective treatment for the acute phase of the virus, we should not forget about the serious consequences of the COVID-19. To do this, we will consider and try to analyze the most dangerous complications after COVID-19. Purpose. To describe the results of the COVID-19 pandemic for the recovered, with a focus on the great need to identify biomarkers that contribute to identifying patients who may develop fibrous interstitial pulmonary pathology (pulmonary fibrosis) at the initial stage of the disease. When detecting COVID-19 manifestations and performing further treatment, it should be borne in mind that the infectious process after the virus is eliminated from the body in most cases does not stop and can turn into long-term lung damage, in particular, fibrous interstitial lung disease. In the literary review, the analysis of modern Russian and foreign (exclusively in English) scientific works significant in relation to the topic of the review and presented in the databases eLibrary, PubMed, Scopus and in the scientific electronic library "Cyberleninka" (Cyberleninka) is carried out.